The journey started with an enigma in the zebrafish embryo: some endothelial cells, actively involved in the initial stages of the development of the earliest blood vessels, were dividing in an ...

The company plans to announce Phase 1b interim data by mid-2026, and the TENACITY-01 study is expected to be completed by late 2028. This timing enables progression to Phase 2 evaluation following ...

A new study published in Science Translational Medicine by researchers at The University of Texas MD Anderson Cancer Center ...

Using drugs that inhibit enzymes called CDK4/6 and CDK2 extends the G1 phase of the cell cycle and helps to slow the growth of drug-resistant breast cancer.

Researchers used miniature human brains grown in the lab to uncover why certain genetic mutations lead to abnormally small ...

A new study published today in Science Translational Medicine by researchers at The University of Texas MD Anderson Cancer ...

Pluri, Inc. (“Pluri”, the “Company”, “we” or “us”) (Nasdaq, TASE: PLUR), a leading biotechnology company leveraging its proprietary platform for cell-based solutions through a collaborative network of ...

The anti-CD40 antibody tegoprubart offers a tacrolimus-free immunosuppression option for preventing islet transplant ...

A missing brain molecule may be disrupting neural wiring in Down syndrome, according to new research. Replacing it in adult mice rewired brain circuits and improved brain flexibility, challenging the ...

A fatty diet doesn’t just damage the liver — it rewires its cells in ways that give cancer a dangerous head start.

A microscopic flaw in the brain’s cellular scaffolding can shape brain size for life.